FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Apotex Verapamil Hydrochloride Extended-Release Recall

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx On…

Apotex Inc. · Toronto, Ontario

Risk level
Class III
Reported by FDA
Oct 7, 2015
Recall ID
D1834-2015
Check your lot numberHow we source this data

Summary

Apotex recalled Verapamil Hydrochloride Extended-Release starting Jul 21, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D1834-2015 on Oct 7, 2015. Reason: Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits. Status: Terminated.

Why it was recalled

Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.

Product description

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

Lot numbers, UPCs & expiration codes

Lot #: KP2621, Exp 8/2015

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D1834-2015
Classification
Class III
Status
Terminated
Recall initiated
Jul 21, 2015
FDA report date
Oct 7, 2015
Quantity
2,075 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Inc.

Original FDA data

Every field from FDA enforcement report D1834-2015, exactly as published.

Show all FDA fields
City
Toronto
State
Ontario
Status
Terminated
Country
Canada
Event ID
72118
Address
150 Signet Drive
Code information
Lot #: KP2621, Exp 8/2015
Report date
Oct 7, 2015
Product type
Drugs
Recall number
D1834-2015
Classification
Class III
Recalling firm
Apotex Inc.
Product quantity
2,075 bottles
Termination date
Feb 15, 2017
Reason for recall
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Jul 21, 2015
Initial firm notification
Letter
Center classification date
Sep 30, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D1834-2015, published Oct 7, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls